A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Validation of the Finnish MD Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer
Tekijät: Ranta, Pihla; Kinnunen, Ilpo; Irjala, Heikki
Kustantaja: Springer Science and Business Media LLC
Kustannuspaikka: BERLIN
Julkaisuvuosi: 2025
Journal: Scientific Reports
Tietokannassa oleva lehden nimi: Scientific Reports
Lehden akronyymi: SCI REP-UK
Artikkelin numero: 18980
Vuosikerta: 15
Numero: 1
Sivujen määrä: 10
ISSN: 2045-2322
eISSN: 2045-2322
DOI: https://doi.org/10.1038/s41598-025-03616-1
Verkko-osoite: https://doi.org/10.1038/s41598-025-03616-1
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/499007041
The aim of this study was to translate and adapt the MD Anderson Dysphagia Inventory (MDADI) questionnaire into Finnish and validate it in patients with head and neck cancer (HNC). A total of 94 participants were included: 64 dysphagic HNC patients and 30 non-dysphagic age- and gender-matched controls. The MDADI was formally translated using the forward-backward method and feasibility, test-retest reliability, internal consistency, score distribution, known-group validity, and patient feedback and were analyzed. Criterion and convergent validities were tested against the previously validated dysphagia questionnaire F-EAT-10. The results showed good variability and no floor or ceiling effects in the dysphagic group (age range 31 to 85 years, mean 67.8, SD 11.2). In all MDADI subscales, the internal consistency reliability was high (Cronbach's alpha > 0.8). Moreover, the intraclass correlation in test-retest (n = 55) was high (> 0.9) in all subscales. The MDADI was able to discriminate between dysphagic and non-dysphagic participants: the mean total score was 73.6 for the dysphagic group and 99.9 for the control group (p > 0.001). The correlations between the MDADI and the F-EAT-10 were strong demonstrating criterion and convergent validities. Patient feedback of the MDADI was positive. In conclusion, the Finnish MDADI is a valid instrument to assess dysphagia-related quality of life in patients with HNC, offering enhanced clinical and research utility.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
Julkaisussa olevat rahoitustiedot:
The authors acknowledge the Vaasa Medical Foundation, the Cancer Society of South-West Finland, the Emil Aaltonen Foundation, the Irja Karvonen Cancer Foundation, the Paulo Foundation, the Cancer Foundation Finland, the Juhani Aho Medical Research Foundation, and the State Research Funding for supporting this work. Moreover, we acknowledge MD, PhD Eeva Haapio, MD, PhD Jarno Velhonoja, MSc (speech and language therapy) Tarja Karttunen, and MSc (nutrition therapy) Nora Loef for participating in the translation process of the Finnish MDADI.
